The aim of this analysis was to firstly characterise the predictive and/or prognostic value of CPT-1A as a biomarker at RNA and protein level using a range of online bioinformatics tools, and secondly to carry out a network analysis on the breast cancer patient cohorts available on the Oncomine platform25 to comprehensively characterise how CPT-1A clusters globally with genes involved in all known cancer hallmarks and epigenetic pathways. This evidence concerns the gene CPT1A and cancer.